The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells
about
The urgent need to recover MHC class I in cancers for effective immunotherapyHDAC inhibitors and immunotherapy; a double edged sword?Current Immunotherapies for Sarcoma: Clinical Trials and RationaleAdvances in sarcoma diagnostics and treatmentAdvancements in the delivery of epigenetic drugsBone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy.Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function.Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association studyEpigenetic suppression of the antitumor cytotoxicity of NK cells by histone deacetylase inhibitor valproic acid.The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3.Histone deacetylase inhibitors as immunomodulators in cancer therapeutics.Epigenetic control of the tumor microenvironment.Therapeutic applications of histone deacetylase inhibitors in sarcoma.Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance.Leveraging natural killer cells for cancer immunotherapy.Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis.Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications.Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis.Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma.Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types
P2860
Q26770165-ED4FB125-3F20-4610-980C-1FC071AA2DE1Q26853102-69BF15FE-0D08-4A11-BA5A-6478D0163303Q28067036-5B081961-A94C-44C8-BBCA-F1D1D017241AQ28069695-E6B23B0A-DE65-45B7-9310-24EFCA9EDD7CQ28088478-23B46279-7BCF-43CF-8D78-D98FB8B9CA16Q35894540-BE39C19A-5AF5-4934-8611-3C204EED427CQ36104946-8C758401-05DC-439D-BD62-E325EF385E9BQ36211604-0A9B2508-7CDA-4B0D-A87C-A433AD42A467Q36853857-0C120A68-C59B-4CB7-A6D5-EF1594E8C94FQ37719306-C1D1AE75-0E3C-4C81-AF95-9942BA410919Q38763747-77B9A592-D9FF-48AD-8191-2124E5FDB635Q38971785-0558CDA6-F99C-49CF-A5BA-4E8366CE91D6Q39450827-A9D55DA0-CF23-4498-916E-6B8DE4EC4CAAQ42042886-246A47A9-1951-4251-9D07-89EC5A399C64Q43865719-2AAF4B10-9DF0-4900-A71B-527596CCDA6AQ47788129-78E08F08-44EA-4C2A-86A7-BCC334A70D77Q47912546-C6DD51C1-CC0D-4351-9F4B-096BC2AD122AQ53613478-34D78C4B-25F9-4DC1-BC6E-4CB689C47255Q55447998-5402BBE4-02BD-4ED0-BA09-F731DCCC352FQ58130496-61B0A8B5-576B-41B0-A1C1-366530B617F9
P2860
The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The narrow-spectrum HDAC inhib ...... ed recognition of cancer cells
@ast
The narrow-spectrum HDAC inhib ...... ed recognition of cancer cells
@en
The narrow-spectrum HDAC inhib ...... d recognition of cancer cells.
@nl
type
label
The narrow-spectrum HDAC inhib ...... ed recognition of cancer cells
@ast
The narrow-spectrum HDAC inhib ...... ed recognition of cancer cells
@en
The narrow-spectrum HDAC inhib ...... d recognition of cancer cells.
@nl
prefLabel
The narrow-spectrum HDAC inhib ...... ed recognition of cancer cells
@ast
The narrow-spectrum HDAC inhib ...... ed recognition of cancer cells
@en
The narrow-spectrum HDAC inhib ...... d recognition of cancer cells.
@nl
P2093
P2860
P1476
The narrow-spectrum HDAC inhib ...... ed recognition of cancer cells
@en
P2093
Cecele J Denman
Ching C Lau
Dennis P M Hughes
Eugenie S Kleinerman
Shiguo Zhu
Stephen M Gottschalk
Zehra S Cobanoglu
P2860
P304
P356
10.1007/S11095-013-1231-0
P577
2013-11-08T00:00:00Z